Raymond James initiated coverage of Praxis Precision (PRAX) with a Strong Buy rating and $815 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRAX:
- 3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
- Praxis: EMBRAVE Data Validate Elsunersen and De‑Risk Pipeline, Supporting Buy Rating on Favorable Risk‑Reward
- Praxis reports positive elsunersen trial in pediatric epilepsies
- Praxis Precision Medicines: Advancing Late-Stage Neurology Pipeline Underpins Outperform Rating and $53 Price Target
- Praxis Precision announces topline results from EMBRAVE Part A trial